KATHARINE SEWELL: Open Payments
NPI 1689199259 · BELCAMP, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 18 payments from 8 companies in 2025. Trend: 2023 $427 · 2024 $872 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $89 |
| ABBVIE INC. | 4 | $85 |
| Indivior Inc. | 2 | $79 |
| Almatica Pharma LLC | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Tris Pharma Inc | 2 | $40 |
| Neurocrine BioSciences, Inc. | 1 | $35 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: VRAYLAR, SUBLOCADE, ARISTADA, LOREEV XR, REXULTI, Dyanavel XR, INGREZZA, LYBALVI.
Industry payments across MD — which companies pay providers there.
